Future Science Group

In this exceptional open dialogue held earlier this year at the 10th WRIB meeting in Orlando (FL, USA), our panel of experts discuss some of the fundamental questions raised with respect to outsourcing in regulated bioanalysis. In part 1 of this panel discussion, a panel of leading CRO and Pharma Directors assess the current situation of outsourcing in bioanalysis, and discuss the direction of outsourcing of regulated bioanalysis in the future. Discussions include: Outsourcing strategies Drivers and business models in outsourcing Scientific exchange and interactions between CROs and Pharmas Sharing and discussing data between CROs and Pharma Cost–effectiveness of outsourcing

In this NCTalks podcast, Alice Weatherston speaks to Lance McCracken, Professor of Behavioral Medicine at King’s College London (UK), about the use of psychological therapies in pain management. In Part 2, we speak to Lance about his work in Acceptance and Commitment Therapy, and his outlook for the future of behavioral therapies in pain management. Summary - A lot of your work has focused on Acceptance and Commitment Therapy (ACT) – can you describe this method of treatment? - What benefits does ACT provide? - How does Acceptance and Commitment Therapy compare to more traditional Cognitive Behavioral Therapy? - What ongoing studies going will progress the understanding of ACT and outcomes for patients? - How do you see the field of pain medicine, and particularly behavioral therapies for the treatment of pain, developing over the next 5–10 years?

In this NCTalks podcast, Alice Weatherston speaks to Lance McCracken, Professor of Behavioral Medicine at King’s College London (UK), about the use of psychological therapies in pain management. In Part 1, Lance outlines the role psychological therapies in chronic pain management and the general attitudes and approaches to such therapies across the medical community. Summary - What are your current research focuses? - What role do psychological therapies play in dealing with chronic pain in patients? - Can psychological interventions be utilized in conjunction with conventional pain medicines such as opioids, or are these mutually exclusive? - Is there reticence towards the use of psychological treatments for pain in the medical community? If so, why is this? - Can psychological treatments be applied to all pain conditions or are some more suited?

In this NCtalks podcast, we speak to Michael Merzenich, a leading professor in neuroplasticity at the University of California, San Francisco (USA), whose team was recently involved in a longitudinal trial into the effect of brain training on cognitive decline and dementia.

In this NCtalks podcast, we speak to Hance Clarke, Director of Pain Services and the Medical Director of the Pain Research Unit at the Toronto General Hospital (ON, Canada).

In this edition of NCtalks, we speak to Michael Merzenich, renowned professor in neuroplasticity.

NCTalks with Michael Merzenich - understanding brain plasticity by Future Science Group

BZTalks: David Griffiths (LGC) on mergers & acquisitions in the bioanalytical field by Future Science Group

BZTalks: Interview with Steven Carr (Broad Institute) on proteomics for personalized medicine by Future Science Group

BZTalks: Chris Beaver (inVentiv Health) on free vs total assays by Future Science Group